Filing Details
- Accession Number:
- 0001209191-19-014009
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-27 14:47:16
- Reporting Period:
- 2019-02-25
- Accepted Time:
- 2019-02-27 14:47:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1388658 | Irhythm Technologies Inc. | IRTC | Surgical & Medical Instruments & Apparatus (3841) | 208149544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1670676 | A David Vort | C/O Irhythm Technologies, Inc. 650 Townsend Street, Suite 500 San Francisco CA 94103 | Evp, Sales | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-25 | 5,044 | $3.65 | 23,846 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-02-25 | 5,044 | $94.85 | 18,802 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-02-25 | 5,044 | $0.00 | 5,044 | $3.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 78,004 | 2015-01-01 | 2024-02-04 | No | 4 | M | Direct |
Footnotes
- The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2018.
- This transaction was executed in multiple trades at prices ranging from $93.85 to $96.00. The price reported above reflects the weightedaverage sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of theissuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
